Chemours
482 hedge funds and large institutions have $3.68B invested in Chemours in 2022 Q1 according to their latest regulatory filings, with 59 funds opening new positions, 156 increasing their positions, 140 reducing their positions, and 75 closing their positions.
13% more funds holding in top 10
Funds holding in top 10: 8 → 9 (+1)
11% more repeat investments, than reductions
Existing positions increased: 156 | Existing positions reduced: 140
0.99% more ownership
Funds ownership: 72.33% → 73.32% (+0.99%)
4% less funds holding
Funds holding: 504 → 482 (-22)
7% less capital invested
Capital invested by funds: $3.95B → $3.68B (-$275M)
21% less first-time investments, than exits
New positions opened: 59 | Existing positions closed: 75
59% less call options, than puts
Call options by funds: $41.8M | Put options by funds: $102M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$127M |
| 2 |
First Trust Advisors
Wheaton,
Illinois
|
+$28M |
| 3 |
AQR Capital Management
Greenwich,
Connecticut
|
+$26.6M |
| 4 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$19.1M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$14.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$41.8M |
| 2 |
SC
Sessa Capital
New York
|
-$36.4M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$35.6M |
| 4 |
Norges Bank
Oslo,
Norway
|
-$32.1M |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$28.5M |
CC Hedge Fund Activity: Q1 2022 in Review
482 of the 6,360 institutional investors tracked by Wall St. Rank reported a position in Chemours (CC) for Q1 2022, worth a combined $3.68B — down 7% from $3.95B a quarter earlier.
Sellers outnumbered buyers: 75 funds closed out of CC and 59 opened new positions — a net loss of 16 holders — while 140 trimmed existing stakes and 156 added.
The largest buyer was BlackRock, adding an estimated $127M. The largest seller was Millennium Management, cutting an estimated $41.8M.
- 482 institutional investors held Chemours (CC) as of Q1 2022, down from 504 in Q4 2021.
- Funds reported $3.68B of Chemours stock for Q1 2022, down 7% quarter-over-quarter.
- 59 funds opened new Chemours positions in Q1 2022 and 75 closed out, a net change of -16 holders.
- The largest Chemours buyer in Q1 2022 was BlackRock, an estimated $127M added.
- The largest Chemours seller in Q1 2022 was Millennium Management, an estimated $41.8M sold.
Based on aggregated 13F filings for Q1 2022.